Securing America’s Generic Drug Supply: Balancing Access and Independence This whitepaper addresses ...
Blog
Use this space to tell everyone about what you have to offer.
This study was run to characterize the real-world CAR-T patient population by describing demographic...
This study was run to characterize patient demographics, cancer indications, treatment patterns, and...
Biomarker testing can drastically extend survival across multiple cancer types. But gaps in adoption...
As the healthcare industry continues to face data challenges, PurpleLab® is making significant inves...
Although randomized controlled trials remain a cornerstone of evidence generation, pharmaceutical an...
Biomarker testing guides selection of targeted therapies in non–small cell lung cancer (NSCLC). Desp...
This article was written by PharmaPhorum. Clinical trials are designed to evaluate the safety and ef...
Download the Webinar Today In pharmaceutical development, where most therapies never reach the marke...
This study was run to understand variations in treatment with resulting shifts in care management th...